Percentage Change in Exercise Tolerance From Baseline at 2 Weeks Baseline and after 2 weeks with each treatment [clinicaltrials_resource:e4a3bd709b46896b20ae86db5e81531b]

Percentage Change in Exercise Tolerance From Baseline at 2 Weeks Baseline and after 2 weeks with each treatment [clinicaltrials_resource:e4a3bd709b46896b20ae86db5e81531b]

Formoterol plus Placebo (Tiotropium)
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:e4a3bd709b46896b20ae86db5e81531b
clinicaltrials:NCT00680056
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Percentage Change in Exercise Tolerance From Baseline at 2 Weeks Baseline and after 2 weeks with each treatment [clinicaltrials_resource:e4a3bd709b46896b20ae86db5e81531b]

Formoterol plus Placebo (Tiotropium)
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:e4a3bd709b46896b20ae86db5e81531b
Bio2RDF identifier
e4a3bd709b46896b20ae86db5e81531b
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e4a3bd709b46896b20ae86db5e81531b
measure [clinicaltrials_vocabulary:measure]
Percentage Change in Exercise Tolerance From Baseline at 2 Weeks
time frame [clinicaltrials_vocabulary:time-frame]
Baseline and after 2 weeks with each treatment
description
Formoterol plus Placebo (Tiotropium)
identifier
clinicaltrials_resource:e4a3bd709b46896b20ae86db5e81531b
title
Percentage Change in Exercise ...... er 2 weeks with each treatment
@en
inDataset
type
label
Percentage Change in Exercise ...... 3bd709b46896b20ae86db5e81531b]
@en